Two Courses with Andy Rosenfarb, ND, L.Ac.
1. Introduction to TCM for Degenerative Eye Disease
This course provides quality information and tools that enable the practitioner to gain genuine confidence translatable to a clinical setting. At the completion of this course the student will have a greater understanding and appreciation for Chinese Medical Ophthalmology, with the ability to develop treatment strategies for patients diagnosed with the main degenerative eye diseases and ophthalmic conditions.
In addition to learning advanced theory in TCM Ophthalmology, you will learn clinical strategies on to how to effectively treat chronic and degenerative eye conditions including Dry Eye, Glaucoma, Cataracts, Diabetic Retinopathy, Macular Degeneration, Retinitis Pigmentosa, Stargardt’s, Usher’s, Retinal Occlusions, Optic Neuritis, Autoimmune Retina and more.
2. Integrative Chinese Medical Ophthalmology with
Dr. Andy Rosenfarb, ND, L.Ac. & Dr.Marc Grossman, OD, L.Ac
Join Dr. Marc Grossman, O.D., L.Ac. and Dr. Andy Rosenfarb, ND, L.Ac as they teach you a western biomedical model of vision, including anatomy, physiology, the visual pathway and a review of major eye conditions, such as macular degeneration, glaucoma, dry eyes, cataracts, and other vision impairments.
In addition, the course will explain a comprehensive TCM approach to common degenerative eye conditions. We will cover basic western diagnostic methods, TCM patterns and treatment strategies; including acupuncture, microcurrent stimulation, moxibustion, tui-na, gwa sha, and Chinese Herbal guidelines for each disease. You will learn how to teach your patients basic home-care utilizing acupressure, Qigong and eye exercises to improve vision.
3. Johns Hopkins University Retinitis Pigmentosa Reasearch Study Protocol
Dr. Rosenfarb recently teamed with researchers at Johns Hopkins University on the first ever clinical study to determine the efficacy of treating Retinitis Pigmentosa with acupuncture and other TCM therapies. Dr. Rosenfarb drew on his extensive training and clinical experience to develop the treatment protocol and trained staff at Johns Hopkins University to administer it to study participants.
Based on the success of that initial study, the NIH is funding a second, expanded clinical study in 2014 that will once again utilize Dr. Rosenfarb’s treatment protocol. The first peer-reviewed study was recently published in Clinical and Experimental Optometry..
This course explains how to properly issue this protocol.
NOTE: This course was originally created as a Certification Course but is no longer offered that way. Disregard the instructions for the tests and the case study requirements.